oxonic acid has been researched along with Gastrointestinal Hemorrhage in 2 studies
Oxonic Acid: Antagonist of urate oxidase.
Gastrointestinal Hemorrhage: Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Adverse events were assessed by the National Cancer Institute Common Terminology Criteria for Adverse Events." | 1.37 | Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 study. ( Asaka, M; Hatanaka, K; Hosokawa, A; Iwanaga, I; Kato, T; Komatsu, Y; Kusumi, T; Miyagishima, T; Nakamura, M; Sakata, Y; Sogabe, S; Yuki, S, 2011) |
| "We treated five gastric cancer patients with chemoradiation therapy consisting of CDDP (6 mg/m2) and S-1 (100 mg/body)." | 1.36 | [The assessment of chemoradiation therapy with CDDP/S-1 for advanced gastric cancer that was actively bleeding]. ( Doi, K; Hirano, Y; Kudo, K; Narita, Y; Ogata, K; Ohchi, T, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, K | 1 |
| Ogata, K | 1 |
| Hirano, Y | 1 |
| Kudo, K | 1 |
| Narita, Y | 1 |
| Ohchi, T | 1 |
| Sogabe, S | 1 |
| Komatsu, Y | 1 |
| Yuki, S | 1 |
| Kusumi, T | 1 |
| Hatanaka, K | 1 |
| Nakamura, M | 1 |
| Kato, T | 1 |
| Miyagishima, T | 1 |
| Hosokawa, A | 1 |
| Iwanaga, I | 1 |
| Sakata, Y | 1 |
| Asaka, M | 1 |
2 other studies available for oxonic acid and Gastrointestinal Hemorrhage
| Article | Year |
|---|---|
[The assessment of chemoradiation therapy with CDDP/S-1 for advanced gastric cancer that was actively bleeding].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Comb | 2010 |
Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 study.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclo | 2011 |